Effects of natural estrogens on the vessel wall;Wirkungen naturlicher Ostrogene auf die Gefasswand: Molekulare Mechanismen und klinische Implikationen

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 41, 1996, Pages 1748-1755

  Luscher T F ^a   Barton, M ^b   Wight, E ^b   Espinosa, E ^b   Yang, Z ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ENDOTHELIN 1;

ATHEROSCLEROSIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; MENOPAUSE; ADULT; AGED; ARTERIOSCLEROSIS; BIOSYNTHESIS; DRUG ANTAGONISM; ENDOTHELIUM; ESTROGEN THERAPY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; ARTERIOSCLEROSIS; CORONARY DISEASE; ENDOTHELIN-1; ENDOTHELIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE;

EID: 0030581571     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. NIH chartbook on cardiovascular, lung, and blood diseases. Washington D.C.: NIH, 1992.
2. Knopp RH: The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol 1988; 72 (Suppl): 23S-30S.
3. Witteman JCM, Grobbee DE, Kok FJ, Hofman A, Valkenburg HA: Increased rise of atherosclerosis in women after the menopause. Br Med J 1989; 298: 642-644.
4. Bundesamt für Statistik: Todesursachen-Statistik. Bern: Bundesamt für Statistik, 1994.
5. Barret-Connor E, Bush T: Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861-1867.
6. Lüscher TF, Vanhoutte PM: The endothelium: modulator of cardiovascular function. Boca Raton: CRC Press, 1990.
7. Colburn P, Bounassisi V: Estrogen-binding sites in endothelial cell cultures. Science 1978; 201: 817-819.
8. Venkov CD, Rankin AB, Vaughan DE: Endothelial cells express estrogen receptors: evidence for a full length mRNA. Circulation 1995; 92 (Suppl): 1-168.
9. Kim-Schulze S, Hubchak SC, McGowan KA, Schnaper HW: Identification of a functional estrogen receptor in human endothelial cells. Circulation 1995; 92 (Suppl): 1-695.
10. Weiner P, Lozasoain I, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-5216.
11. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O: 17β-estradiol stimulates prostacyclin but not endothelin-1 production in human vascular endothelial cells. J Clin Endocrinol Metab 1995; 80: 1832-1836.
12. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verbeugt FW, Gooren LJ: Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993; 118: 429-432.
13. Ylikorkala O, Orpana A, Puolakka J, Pyorala T, Viinikka L: Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 1995; 80: 3384-3387.
14. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
15. Yang Z, Julmy F, Mohadjer A, Gerbach P, Althaus U, Lüscher TF: 17β-oestradiol inhibits growth of human vascular smooth muscle: similar effects in cells from females and males. Eur Heart J 1995; 16 (Suppl.): 193.
16. Karas RH, Patterson BL, Mendelsohn ME: Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943-1950.
17. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F et al.: 17β-estradiol inhibits proliferation and migration of human vascular smooth muscle cells. Cardiovasc Res 1996; (in press).
18. Mügge A, Riedel M, Barton M, Kuhn M, Lichtlen M: Endothelium-independent relaxation by 17β-oestradiol of human coronary arteries in vitro. Cardiovasc Res 1993; 27: 1939-1942.
19. Barton M, Riedel M, Mügge M: 17β-estradiol dilates both human internal mammary and coronary arteries by an endothelium-independent mechanism. Naunyn-Schmiedeberg's Arch Pharmacol 1993; 347 (Suppl.): 43.
20. Pappas TC, Gametchu B, Watson CS: Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J 1995; 9: 404-410.
21. Hardy PS, Valverde MA: Novel plasma membrane action of estrogen and antiestrogens revealed by their regulation of a large conductance chloride channel. FASEBJ 1994; 8: 760-765.
22. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992; 106: 739-745.
23. 2 in porcine coronary artery. Circulation 1995; 91: 2619-2626.
24. Mügge A, Barton M, Riedel M, Lichtlen PR: Contractions induced by histamine, serotonin, and angiotensin II are impaired by 17β-oestradiol in human arteries in vitro. Circulation 1995; 92 (Suppl): 1-431.
25. Barton M, Mügge A, Riedel M, Lichtlen PR: Wirkung von 17β-Oestradiol auf die Endothel-abhängige Relaxation von menschlichen Mammaria- und Koronararterien. Z Kardiol 1995; 84 (Suppl): 44.
26. Volterrani M, Rosano G, Coats A, Beale C, Collins P: Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995; 99: 119-122.
27. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon ROr: Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 1995; 75: 264-268.
28. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S et al.: 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30.
29. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P: Beneficial effect of estrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993; 342: 133-136.
30. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B et al.: Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325: 726-762.
31. Colditz GA, Hankinson SE, Hunter DJ, Willet WC, Manson JE et al.: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-1593.